Troikaa Pharmaceuticals Ltd.
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- NCA tablet 800 mg+50 mg
- C01 - Terapia cardíaca
- DOBUCIN concentrate for solution for infusion 250 mg/5 ml
- DOPACIN concentrate for solution for infusion 200 mg/5 ml
- DOPAMINE TROIKAA concentrate for solution for infusion 200 mg/5 ml
- EURYTHMIC solution for infusion 150 mg/3 ml
- EURYTHMIC tablet 100 mg
- EURYTHMIC tablet 200 mg
- C07 - Betabloqueantes
- ESMOCARD solution for injection 100 mg/10 ml
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- OCTOTIDE solution for injection 100 µg/1 ml
- OCTOTIDE solution for injection 50 µg/1 ml
- J01 - Antibacterianos para uso sistémico
- FORTACEF powder for solution for injection 1 g
- FORTACEF powder for solution for injection 250 mg
- FORTACEF powder for solution for injection 500 mg
- NADIX ACUTAB dispersible tablet 300 mg
- J05 - Antivirales de uso sistémico
- VIR powder for solution for injection 250 mg
- M01 - Antiinflamatorios y antirreumáticos
- CARTILAMINE FORTE tablet 250 mg+200 mg
- CARTILAMINE SR prolonged-release tablet
- CARTILAMINE tablet 500 mg
- CARTILAMINE tablet 500 mg+400 mg
- CARTILAMINE TOTAL tablet
- DYNAPAR gastro-resistant tablet 100 mg
- DYNAPAR gastro-resistant tablet 50 mg
- DYNAPAR LD gastro-resistant capsule, hard 50 mg+500 mg
- DYNAPAR PPI prolonged-release capsule, hard 100 mg+20 mg
- DYNAPAR prolonged-release tablet 100 mg
- DYNAPAR prolonged-release tablet 75 mg
- DYNAPAR suppository 50 mg
- DYNAPAR tablet 50 mg+500 mg
- N01 - Anestésicos
- KETAMAX solution for infusion 100 mg/10 ml
- KETAMAX solution for infusion 100 mg/2 ml
- KETAMAX solution for infusion 500 mg/10 ml
- N05 - Psicolépticos
- BENZOSED solution for injection 10 mg/10 ml
- BENZOSED solution for injection 5 mg/1 ml
- BENZOSED solution for injection 5 mg/5 ml
- V03 - Todos los demás preparados terapéuticos
- NARCOTAN solution for injection 200 µg/1 ml
- NARCOTAN solution for injection 400 µg/1 ml